SVVB yields 11.36% · ABBV yields 3.12%● Live data
📍 ABBV pulled ahead of the other in Year 4
Combined, SVVB + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SVVB + ABBV for your $10,000?
Savi Financial Corporation, Inc. operates as a financial holding company for SaviBank that provides various commercial banking products and services for small and middle-market businesses, and individuals in and around Skagit, Island, and Whatcom counties in the United States. It offers checking accounts, savings accounts, money market accounts, certificates of deposit, and individual retirement accounts. The company also provides commercial real estate, commercial term, government guaranteed small business lending, and small business administration disaster loans, as well as commercial lines of credit; home loans; and auto loans, boat or other recreational vehicle loans, home equity fixed rate loans, and home equity line of credit. In addition, it offers remote deposit capture services; merchant card services; cash management services, such as ACH transactions, account transfer, bill pay, and online wire transfer services; and credit and debit cards. Further, the company provides online banking services. It operates through nine branch locations in Anacortes, Burlington, Bellingham, Concrete, Mt.Vernon, Oak Harbor, Sedro-Woolley, and Freeland, Washington. Savi Financial Corporation, Inc. was founded in 2005 and is based in Burlington, Washington.
Full SVVB Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.